NovoSeven® Kısa Ürün Bilgisi
Hedner U. Blood Rev 2015;29(S1):S4–S8.
Hemlibra® Kısa Ürün Bilgisi
FEIBA® Kısa Ürün Bilgisi
Obizur® Kısa Ürün Bilgisi
Santagostino E et al. Thromb Haemost 2006;4(2):367–371.
Neufeld EJ et al. Pediatr Blood Cancer 2013;60(7):1178–1183.
Pruthi RK et al. Thromb Haemost 2007;98(4):726–732.
Shapiro AD et al. Thromb Haemost 1998;80(5):773–778.
Parameswaran R et al. Haemophilia 2005;11(2):100–106.
Hay CR et al. Thromb Haemost 1997;7(8):1463–1467.
Amano K et al. Haemophilia 2016;23(1):50–58.
Baudo F et al. Blood 2012;120(1):39–46.
Borel-Derlon A et al. Haemophilia 2016;22 Suppl 4:3–138. Poster PO-W-4.
Sumner MJ et al. Haemophilia 2007;13(5):451–461.
Lentz SR et al. J Blood Med 2014;5:1–3.
Sun B et al. Br J Haematol 2019. doi: 10.1111/bjh.16128. [Epub ahead of print].
Pardos-Gea J et al. Haemophilia 2018;24(3):e163–e166.
Tiede A, Worster A. Ann Hematol 2018;97(10):1889–1901.
Abshire T, Kenet G. Haemophilia 2008;14(5):898–902.
Rexen P et al. TH Open 2019;3:e45–e49.
Pollard D et al. J Haem Pract 2017;4(1):1–5.
Neufeld EJ et al. Blood Rev 2015;29(S1):S34–S41.
Lavigne-Lissalde et at. J of Thromb and Haem, 13: 520–529.
Hedner U. Blood Rev 2015;29(S1):S4–S8.
Neufeld EJ et al. Haemophilia 2011;17:650–656.
Neufeld EJ et al. Haemophilia 2018;24(4):e275–e277.
Lavigne-Lissalde G et al, Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial Journal of Thrombosis and Haemostasis, 13: 520–529